Current Controversies in Newer Therapies to Treat Birth Asphyxia

Despite major advances in monitoring technology and knowledge of fetal and neonatal pathophysiology, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the main causes of severe adverse neurological outcome in children. Until recently, there were no therapies other than supportive measure...

Full description

Saved in:
Bibliographic Details
Main Author: Pia Wintermark
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:International Journal of Pediatrics
Online Access:http://dx.doi.org/10.1155/2011/848413
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558667383177216
author Pia Wintermark
author_facet Pia Wintermark
author_sort Pia Wintermark
collection DOAJ
description Despite major advances in monitoring technology and knowledge of fetal and neonatal pathophysiology, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the main causes of severe adverse neurological outcome in children. Until recently, there were no therapies other than supportive measures. Over the past several years, mild hypothermia has been proven to be safe to treat HIE. Unfortunately, this neuroprotective strategy seems efficient in preventing brain injury in some asphyxiated newborns, but not in all of them. Thus, there is increasing interest to rapidly understand how to refine hypothermia therapy and add neuroprotective or neurorestorative strategies. Several promising newer treatments to treat birth asphyxia and prevent its devastating neurological consequences are currently being tested. In this paper, the physiopathology behind HIE, the currently available treatment, the potential alternatives, and the next steps before implementation of these other treatments are reviewed.
format Article
id doaj-art-7db7e3caae2842e8a4ac4d018c1f19c1
institution Kabale University
issn 1687-9740
1687-9759
language English
publishDate 2011-01-01
publisher Wiley
record_format Article
series International Journal of Pediatrics
spelling doaj-art-7db7e3caae2842e8a4ac4d018c1f19c12025-02-03T01:31:56ZengWileyInternational Journal of Pediatrics1687-97401687-97592011-01-01201110.1155/2011/848413848413Current Controversies in Newer Therapies to Treat Birth AsphyxiaPia Wintermark0Division of Newborn Medicine, Montreal Children's Hospital, McGill University, 2300 Rue Tupper, C-920, Montreal, QC, H3H 1P3, CanadaDespite major advances in monitoring technology and knowledge of fetal and neonatal pathophysiology, neonatal hypoxic-ischemic encephalopathy (HIE) remains one of the main causes of severe adverse neurological outcome in children. Until recently, there were no therapies other than supportive measures. Over the past several years, mild hypothermia has been proven to be safe to treat HIE. Unfortunately, this neuroprotective strategy seems efficient in preventing brain injury in some asphyxiated newborns, but not in all of them. Thus, there is increasing interest to rapidly understand how to refine hypothermia therapy and add neuroprotective or neurorestorative strategies. Several promising newer treatments to treat birth asphyxia and prevent its devastating neurological consequences are currently being tested. In this paper, the physiopathology behind HIE, the currently available treatment, the potential alternatives, and the next steps before implementation of these other treatments are reviewed.http://dx.doi.org/10.1155/2011/848413
spellingShingle Pia Wintermark
Current Controversies in Newer Therapies to Treat Birth Asphyxia
International Journal of Pediatrics
title Current Controversies in Newer Therapies to Treat Birth Asphyxia
title_full Current Controversies in Newer Therapies to Treat Birth Asphyxia
title_fullStr Current Controversies in Newer Therapies to Treat Birth Asphyxia
title_full_unstemmed Current Controversies in Newer Therapies to Treat Birth Asphyxia
title_short Current Controversies in Newer Therapies to Treat Birth Asphyxia
title_sort current controversies in newer therapies to treat birth asphyxia
url http://dx.doi.org/10.1155/2011/848413
work_keys_str_mv AT piawintermark currentcontroversiesinnewertherapiestotreatbirthasphyxia